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Background
Antimicrobial drugs are a precious but finite resource, dif-
ferent from other drugs. They are the only drugs that do not 
directly affect the patient but instead affect the growth, and 
ecology of invading pathogens and commensal microorganisms. 
Antimicrobial therapy is not only based on the characteristics 
of a patient and a drug, but also on the characteristics of the 
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widespread antimicrobial use has compromised its value, 
leading to a crisis of antimicrobial resistance. a major 
cause of misuse is insufficient knowledge of prescribing 
of antimicrobials in many categories of professionals. an 
important principle of antimicrobial stewardship is avoiding 
selection pressure in the patient, both on pathogen and 
commensal by avoiding unnecessary use, choosing the least 
broad-spectrum antibiotic, adequate doses, a good timing and 
the shortest possible duration. up to now, most educational 
efforts have been targeted at professionals (mostly medical 
doctors) after their training and at the adult public. in the past 
few years, progress has been made in educating children. 
it is now crucial that academia and ministries of health and 
education jointly focus on an adapted undergraduate medical/
professional curriculum that teaches all necessary principles of 
microbiology, infectious diseases and clinical pharmacology, 
with emphasis on the principles of prudent prescribing.
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microorganisms causing the infection and the colonizing flora. 
A useful didactic tool that describes the complex interrelation-
ship between humans, microorganisms and antimicrobial drugs 
is the pyramid of infectious diseases (Fig. 1). The arrows in the 
pyramid visually illustrate the multiple interactions between 
the patient, the drug, the pathogen(s) and colonizing micro-
flora. Activity of the antimicrobial drug is obtained at the cost 
of the development of resistance by the pathogen, but also the 
colonizing flora. As is shown in the pyramid (Fig. 1), the choice 
of the appropriate antimicrobial therapy is a complex decision, 
depending on the knowledge of many different aspects of infec-
tious diseases: immunological and genetic host factors, micro-
bial virulence, pharmacokinetics and -dynamics (PK/PD) of 
drugs.
Prescribers of antimicrobial drugs have dual, somewhat con-
tradictory responsibilities. On the one hand they want to offer 
optimal therapy for the individual patient under their care; on 
the other hand they have a responsibility to the same and other 
patients in the future and to public health to preserve the effi-
cacy of antibiotics and minimize the development of resistance. 
The former responsibility tends to promote overtreatment; the 
latter is usually overlooked. Among antimicrobial drugs, those 
targeting bacteria, i.e., antibiotics, are most extensively developed 
and prescribed. Misuse of antibiotics, i.e., unnecessary prescrip-
tions as well as inappropriate use (inadequate dosing, wrong 
duration) is frequent; up to half of the antibiotic prescriptions 
both in the community and in hospitals are considered unjus-
tified.1,2 Bacterial resistance to antibiotics is a serious threat to 
patients that is increasing rapidly. With few new antibiotics in 
the research and development pipeline, particularly in the Gram-
negative spectrum,3 and “old” useful antibiotics, which are not 
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(www.dobugsneeddrugs.org) and across Europe the European 
Centre for Disease Prevention and Control (ECDC)’s annual 
European Antibiotic Awareness Day (http://ecdc.europa.eu/
en/eaad/Pages/Home.aspx), launched on 18 November 2008. 
Huttner et al. identified and reviewed the characteristics and out-
comes of 22 campaigns done at a national or regional level in 
high-income countries between 1990 and 2007.14 The intensity 
of the campaigns varied widely, from simple internet to expensive 
mass-media campaigns. All but one campaign targeted the public 
and physicians simultaneously. The authors conclude that public 
campaigns can probably contribute to more careful use of anti-
biotics in outpatients, at least in high-prescribing countries.14 In 
France yearly public antibiotic campaigns have been conducted 
since 2002. During its first 3 years, the French public campaign 
accelerated a pre-existing decrease in ambulatory antibiotic pre-
scriptions. However, the decrease in consultation rates suggests 
that altered illness behavior of patients may have contributed to 
the observed decline.15
Because of the major deficiencies found in elementary knowl-
edge on antibiotics in surveys of adults throughout Europe (e.g., 
“antibiotics are useful for colds”), educating children on this 
topic might be a good idea. Three major initiatives have been 
directed to the education of children. The first program, Do Bugs 
Need Drugs? started as a small six-month pilot in Alberta, Canada 
in 1998. It contained a kids’ section dealing with handwashing 
and responsible use of antibiotics in a playful way. The program 
evolved into a larger provincial program in Alberta and British 
marketed anymore in some coun-
tries,4 prudent antibiotic use is the 
only option to delay the emergence 
of resistance.
The quantity and quality of anti-
biotic prescribing differs greatly 
between countries. This has become 
clear in international comparative 
studies on antibiotic prescribing in 
a quantitative and qualitative fash-
ion.5,6 For instance, the amount 
of antibiotics used in southern 
European countries is about three 
times higher than in Scandinavian 
countries or the Netherlands.7 In 
general, these differences in use 
are reflected by the magnitude of 
the antimicrobial resistance prob-
lems: the more (broad-spectrum) 
antibiotics are used, the greater the 
prevalence of resistant microorgan-
isms leading to a spiral of escalating 
broad-spectrum use.
As early as in 1993, the 
British Society of Antimicrobial 
Chemotherapy (BSAC) Working 
Party on Antimicrobial Use consid-
ered training in infectious diseases 
(ID) and knowledge of prescribing of 
antimicrobial drugs insufficient in clinicians, which is one of the 
major causes of misuse.8 According to a recent policy paper by the 
Infectious Diseases Society of America (IDSA), clinician train-
ing and continuing education in appropriate antimicrobial use 
in the United States (US) is “highly variable, non standardized, 
infrequent, and highly prone to bias, especially when conveyed 
or sponsored by pharmaceutical firms or their agents. Apart from 
initial training and, to a limited extent, in preparation for board 
recertification examinations, there is little if any compulsory 
training or education of physicians in antimicrobial steward-
ship.”9 Conversely, focus on prescribing older, narrow-spectrum 
drugs in targeted therapy has been taught in medical schools and 
has been common practice in northern European countries such 
as Scandinavia and the Netherlands for several decades.10
National and international authorities have repeatedly recom-
mended multifaceted strategies to promote prudent antibiotic use 
for the control of antibiotic resistance.11,12 One of these strate-
gies is to optimize education of all healthcare professionals who 
prescribe antibiotics. Because patients have an increasingly par-
ticipative role in their treatment, education of the public is also 
of the utmost importance. Until recently the public’s knowledge 
on antibiotics—appropriateness, side effects and limitations—
was poor in the European Union (EU).13 In the last decade, 
national and regional campaigns have been conducted to edu-
cate the public worldwide; e.g., in the US the Centers for Disease 
Control and Prevention (CDC)’s Get Smart about Antibiotics 
(www.cdc.gov/getsmart/), in Canada Do Bugs Need Drugs? 
Figure 1. the pyramid of infectious diseases. it describes the complex interrelationship between 
humans, microorganisms and antimicrobial drugs. the arrows in the pyramid illustrate the multiple 
interactions between the patient, the drug, the pathogen(s) and colonizing microflora. activity of the 
antimicrobial drug is obtained at the cost of the development of resistance by the pathogen, but also 
the colonizing flora.
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A lack of knowledge of infectious disease and antibiotics may 
seriously hamper the quality of prescription. In this situation, the 
prescribing physician may prefer to err on the safe side, i.e., pre-
scribing maximal broad-spectrum treatment, instead of making 
a well-informed guess. A negative attitude, based on a lack of 
agreement with protocols or guidelines, will also affect prescrib-
ing. Likewise, a lack of self-efficacy, a lack of outcome expectancy 
and inertia may lead to poor prescribing.17 Based on the avail-
able international recommendations for antimicrobial steward-
ship policies and on the literature,1,18 Table 1 presents the main 
principles for education in prudent antibiotic prescribing. These 
elements have to be translated into topics, concepts, disciplines, 
learning outcomes and competencies both for the undergraduate 
core curriculum of medical doctors and other healthcare profes-
sionals, the internship/foundation year and specialty/professional 
training.
Who are the Prescribers of Antibiotics?
Unlike many other drugs, for which prescribing is kept within 
a specialty (for example neuroleptic drugs), antibiotics are pre-
scribed universally by all medical doctors and dentists in the 
community. In Europe, over the counter use by the public is low 
except for a few southern countries (e.g., Spain and Greece).19 
But even in the case of over the counter purchases, health pro-
fessionals have a major responsibility as patients copy their pre-
scribing habits.20 In some countries [for example the United 
Kingdom (UK) or France], midwives, clinical pharmacists 
or nurses (“physician assistants,” in the UK, Netherlands and 
Belgium) can also prescribe some antibiotics in selected clinical 
situations.21,22 Pharmacists also play a key role in the process, by 
dispensing the drugs and giving advice to the patients. Therefore, 
all healthcare professionals in contact with the patient must be 
educated with respect to knowledge on antimicrobial resistance, 
(lack of) evidence of benefit of antibiotics in different conditions 
and related beliefs, knowledge of management of symptoms and 
the use of microbiology laboratory tests to guide antibiotic treat-
ment. Education on management of demanding patients is also 
required.23
Antibiotic management requires effective teamwork between 
all health professions, regardless of who writes the prescription. It 
is therefore crucial to educate not only prescribers, but all other 
healthcare professionals in contact with the patients who are pre-
scribed an antibiotic (e.g., nurses, midwives and pharmacists), 
since patients should receive consistent messages on correct and 
prudent antibiotic use when taking antibiotics.24 Therefore, all 
these healthcare professionals must receive continuous training 
in prudent antibiotic prescribing.24,25
In hospitals, only patients with complicated or severe infec-
tions will be referred to infectious diseases departments or medi-
cal microbiologists or infectious diseases teams for consultation, 
the majority being treated for their infection by other physi-
cians, mostly organ specialists. On average, one patient out of 
three is treated with antibiotics during his hospital stay. In the 
recent national English Point Prevalence Survey on healthcare- 
associated infections and antimicrobial use report, the prevalence 
Columbia (www.dobugsneeddrugs.org). Second, the Microbes en 
question mobile children’s health education campaign, supported 
by the French Caisse Nationale d’Assurance Maladie and the 
Pasteur Institute, was started as an innovative program in 2004. 
Finally, the European Union-funded antibiotic and hygiene 
teaching resource e-Bug was developed in the UK as an initiative 
of the Health Protection Agency. In preparation of the program, 
Lecky et al. examined the educational structure and educational 
resources or campaigns currently available by questionnaire in 
10 European countries.16 It appeared that the curricula in all 
countries covered the topic of human health and hygiene, but 
limited information was provided on antibiotics and their pru-
dent use. The European educational structure from pre-primary 
through upper secondary indicated that the 9- to 11-year-old and 
12- to 15-year-old age groups were the most appropriate to aim 
the e-Bug resource at, in order to teach all children within com-
pulsory education.16 In conclusion, such programs constitute an 
opportunity for instructing children and their parents on the use 
and non-use of antibiotics. Further details on education of the 
public are beyond the scope of this article.
In this article we will focus on education of the prescribers of 
antibiotics, and analyze and discuss all relevant aspects. We will 
review the principles of antimicrobial stewardship, the timeline 
and setting for this educational process and learning outcomes, 
the background of the teachers, the format of education, its eval-
uation and show the need for early and integrated education of 
all medical professionals.
Antimicrobial Stewardship Principles
According to the IDSA definition of antimicrobial stewardship 
it includes: optimizing the indication, selection, dosing, route of 
administration and duration of antimicrobial therapy to maxi-
mize clinical cure or prevention of infection while limiting the 
collateral damage of antimicrobial use, including toxicity, selec-
tion of pathogenic organisms (such as Clostridium difficile) and 
emergence of resistance.1 An important principle is avoiding 
selection pressure of the antibiotic in the patient, both on patho-
gen and commensal (Fig. 1) by choosing the least broad-spec-
trum antibiotic, adequate doses, a good timing and the shortest 
possible duration. With resistance increasing worldwide, addi-
tional uncertainty arises on the optimal broadness of spectrum 
needed for empirical therapy. The level of in vitro resistance that 
should guide the abandonment of an antibiotic and the shift 
to a broad-spectrum agent is not known. Antibiotic choices for 
empirical therapy should be decided upon at local level, guided 
by local antibiograms and patient outcome data. However, in 
settings with a well-developed microbiology laboratory system, 
it is possible to adapt the empirical therapy to a targeted ther-
apy when culture results become available; streamlining or de- 
escalating antimicrobial therapy has become more widely 
accepted since intensive care physicians have adopted it as their 
strategy. Targeted therapy decreases unnecessary antimicrobial 
exposure and contains costs. De-escalation may also include dis-
continuation of empirical antimicrobial therapy based on clinical 
criteria and negative culture results.1
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• Extent, causes of bacterial resistance in pathogens (low antibiotic 
concentration, longtime exposure of microorganisms to antibiotics is 
driving resistance)
• Extent, causes of bacterial resistance in commensals and the phenom-
enon of overgrowth (e.g., Clostridium difficile infection, yeast infection)
epidemiology
• Epidemiology of resistance, accounting for local variations and  




• Spread of resistant organisms
Antibiotics




• Broad vs. narrow-spectrum antibiotics, preferred choice of narrow-
spectrum drugs
• Combination therapy (synergy, limiting emergence of resistance, 
broaden the spectrum)
costs
ethics, public health, 
pharmacology
• Collateral damage of antibiotic use (toxicity, cost)
• Consequences of bacterial resistance







• Interpretation of clinical and laboratory biological markers
• Fever and C-Reactive Protein (CRP) elevation are also a sign of  
inflammation, not per se of an infection
isolation, identification of 
bacteria, viruses and fungi
(micro) biology
• Practical use of point-of-care tests (e.g., urine dipstick, streptococcal 
rapid antigen diagnostic test in tonsillitis...)
• Importance of taking microbiological samples for culture before  
starting antibiotic therapy













• Definitions and indications of empiric/directed therapy vs. prophylaxis
• Clinical situations when not to prescribe an antibiotic:
• Colonization vs. infection (e.g., asymptomatic bacteriuria)
• Viral infections (e.g., acute bronchitis)
• Inflammation vs. infection (e.g., fever without a definite diagnosis in a 















• Documentation of antimicrobial indication in clinical
notes











• Best bacteriological guess for empiric therapy
• Choice in case of prior use of antibiotics when selecting an antibiotic 
for empiric therapy
• Choosing the dose and interval of administration (basic principles  
of pK/pd)




communication with the 
microbiology laboratory
value of specialist  






• Reassessment of the antibiotic prescription around day 3
• Streamlining/de-escalation once microbiological results are known
• IV-oral switch (bioavailability of antibiotics)
• Therapeutic drug monitoring to ensure adequate drug levels (e.g., 
vancomycin)
*a competency is a quality or characteristic of a person that is related to effective performance. competencies can be described as a combination of 
knowledge skills, motives and personal traits.22
Table 1. elements of education on prudent antibiotic prescribing
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the importance of guide-
lines in clinical practice
clinical medicine, organ 
specialists
• Prescribing antibiotic therapy according to national/local practice 
guidelines
Quality indicators of anti-
biotic use
Quality institute





psychology, clinical  
medicine
• Explaining to the patient the absence of an antibiotic prescription
• Education of patients regarding prudent antibiotic use (comply with 
the doctors’ prescription, no self-medication...)
*a competency is a quality or characteristic of a person that is related to effective performance. competencies can be described as a combination of 
knowledge skills, motives and personal traits.22
antimicrobial use to identify gaps in medical education in a 
US university hospital.33 Thirty percent of medical students 
responded. The majority of third- and fourth-year medical stu-
dents believed that antibiotics were overused in the hospital and 
in outpatient areas. Medical students recognized the importance 
of judicious antibiotic use and would like greater instruction on 
how to choose antibiotics appropriately. Over three-quarters of 
the students would like more education on antibiotic selection, 
and 83% wanted this education to be during the third year of 
medical school. The resources they used the most for antibiotic 
selection included other physicians and handheld programs such 
as Epocrates, but no clear resource emerged as the dominant pref-
erence.33 Pulcini et al. conducted a survey on doctors after quali-
fication from medical school who were still in their training years 
in a French and Scottish university hospital.29 In both countries, 
doctors were first-year trainees at the same stage in their medical 
training, after 5 and 6 years of undergraduate training in Dundee 
and Nice, respectively. Overall, 30% of those surveyed stated 
that they had had no training in antibiotic prescribing in the 
past year, although 99% had prescribed an antibiotic within the 
last 6 mo. A reassuring feature was that 91% (France) and 97% 
(Scotland) cited guidelines as a factor that influenced their pre-
scribing, respectively.29 One of the striking differences is that US 
students did not mention local guidelines as a resource,33 whereas 
British students are explicitly stimulated to prescribe according 
to local guidelines.22
Recently, the importance of undergraduate training in pru-
dent prescribing of antibiotics has become increasingly recog-
nized.12,23 In the UK and Scotland in particular, major efforts 
were made to adapt and revise undergraduate education on 
antibiotics. In the UK, the Specialist Advisory Committee on 
Antimicrobial Resistance (SACAR) has proposed to undertake 
the development of learning outcomes, i.e., statements that indi-
cate what a student should know, understand and be able to do 
by the end of an educational program. This would provide a 
robust and transparent framework for curriculum development 
at all stages. Subsequently, the learning outcomes could be trans-
lated into competencies by the appropriate bodies.25 Prescribing 
is included as a component of the undergraduate program in the 
UK, and the importance of undergraduate training in prescribing 
is reflected in aspects of the General Medical Council’s (GMC’s) 
Tomorrows’ Doctors.34 The GMC has now endorsed the report 
entitled A single competency framework for all prescribers, as in the 
UK nurses are allowed to prescribe antibiotics.22 Doctors should 
of national antimicrobial use was 34.7%.26 It was greatest in the 
intensive care units (ICUs) (60.8%) and antimicrobial use preva-
lence in surgery was 36%.26 Junior doctors of all specialties often 
prescribe the antibiotics under the supervision of their seniors. 
Therefore, both senior and junior doctors must be educated in 
order to change practice.27-29
Finally, we must also consider the antibiotic prescriptions for 
animals and agriculture, made by the veterinarians. Although 
there are similarities of antimicrobial stewardship for companion 
animals and the human sector,30 antibiotic use in livestock ani-
mals is further complicated by economic issues.31 An enormous 
challenge is awaiting those wanting to introduce antibiotic stew-
ardship in the undergraduate veterinarian curriculum.32
When Should Antimicrobial Stewardship  
Education Start?
Figure 2 shows the timeline of education on prudent antibiotic 
use of both the patients and the prescribers of antimicrobials. As 
mentioned above, in the past few years a lot of progress has been 
made in teaching of children. Education at the primary and sec-
ondary level will prepare the individual who later might become 
a patient or more importantly, the anxious parent of a sick tod-
dler with, for example, otitis media. In addition, it provides the 
basic education of the future professional. Not much is known 
about the content, volume and quality of medical curricula 
teaching antimicrobial stewardship principles and resistance in 
terms of knowledge, attitude and behavior to medical students, 
and more specifically, their timeline in Europe. One survey was 
done by the British Society for Antimicrobial Chemotherapy.8 
The authors pleaded for inclusion of antimicrobial chemotherapy 
in the undergraduate curriculum, as most doctors regularly treat 
infections. European national medical undergraduate curricula 
can either be quite detailed such as the Raamplan Artsopleiding 
2009 in the Netherlands in which general learning outcomes 
with keywords are specified such as: prevention of infections and 
spread, aspects of guidelines and protocols and development of 
antibiotics. Other learning outcomes of university curricula such 
as the University of Leuven on websites (http://med.kuleuven.
be/Faculteit_Geneeskunde/english/studies/medicine) are very 
general and do not provide information on the topics covered. 
Indirect information is available from a few surveys of medi-
cal students or junior doctors.29,33 Minen et al. surveyed medi-
cal students’ perceptions and attitudes about their training on 
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school. Conversely, a plethora of literature is available on the dif-
ficult task of changing the behavior of trained medical practitio-
ners, the barriers being multiple, cultural among others.17,36
Who Should Educate/Teach/Train?
As all doctors prescribe antibiotics, a strong input is needed from 
academia to transfer the knowledge in the undergraduate cur-
riculum. As depicted in Table 1, the curriculum is expected to 
deliver knowledge and shape the right attitude and behavior 
regarding the basic principles of antimicrobial stewardship. In 
most settings the organ specialist hardly covers this topic. A wide 
variety of disciplines must be involved, including epidemiology, 
ethics and communication skills (working with guidelines, com-
municating with the patient). To link the undergraduate and 
postgraduate programs, in particular in the period of intern-
ship/foundation training, close collaboration between healthcare 
providers and academicians and between hospitals and medical 
schools is needed.
In the postgraduate training track most medical and sur-
gical specialties are anatomically defined, but all have to deal 
with infections. In practice, each specialty thus has a certain 
degree of “claim” over antimicrobial prescribing in their field. 
Again, as depicted in Table 1, the input of many disciplines 
is required to train a junior prescriber at the bedside, and the 
be able to prescribe on registration. In the UK, this competency 
is subjected to the standards for supervision for doctors in train-
ing set out in The Trainee Doctor report.35 Statement competency 
examples are: (1) Competency 1: Knowledge. Has up-to-date 
clinical, pharmacological and pharmaceutical knowledge relevant to 
own area of practice, Nr 11: Understands antimicrobial resistance 
and the roles of infection prevention, control and antimicrobial 
stewardship measures; (2) Competency 7: The Healthcare sys-
tem. Understands and works within local and national policies, 
processes and systems that impact on prescribing practice. Sees how 
own prescribing impacts on the wider healthcare community, Nr 59: 
Understands and works within local frameworks for medicines 
use as appropriate (e.g., local formularies, care pathways, proto-
cols and guidelines). More specific learning outcomes or compe-
tencies can be developed departing from this list.
Re-examining the principles and learning outcomes in Table 1, 
it is clear that much emphasis is needed on the transfer of basic 
science knowledge at an early stage. Just as optimal periods and 
subjects have been identified to guarantee maximal exposure to 
children,16 the undergraduate curriculum and internship/foun-
dation year seem optimal stages to build a solid knowledge base 
for later practice. For example: surgeons will have a much higher 
acceptance of prophylaxis guidelines if they have been exposed to 
the principles of guideline development and antibiotic prophy-
laxis taught as core competencies in the third year of medical 
Figure 2. timeline of education on prudent antibiotic use. different time periods which offer opportunities to shape or change the behavior of the 
public and the prescribers of antibiotics.
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Learning societies such as the ESCMID (European Society of 
Clinical Microbiology and Infectious Diseases) Study Group for 
Antibiotic Policies (ESGAP) have been organizing educational 
workshops on antibiotic stewardship for more than 10 years. 
Table 2 presents a selection of the main learning outcomes for 
such workshops. The format of these postgraduate educational 
courses is discussed in the next paragraph.
How to Educate? Formats of Educational Curricula
Undergraduate. In the undergraduate curriculum, classical for-
mal lectures are seldom considered as a successful means of trans-
ferring knowledge. Over the past decade, problem-based learning 
has been introduced in many universities. This type of education 
allows for alternative formats of interactive learning in smaller 
student groups. It is important to identify the topics or concepts 
that benefit from a disease- (e.g., acute bronchitis) or problem- 
(e.g., antimicrobial resistance) oriented rather than a pathogen- 
(e.g., MRSA, methicillin-resistant Staphylococcus aureus) oriented 
or a drug- (e.g., antibiotic classes) oriented approach.
Microbial resistance can be part of microbiology teaching, 
information on antibiotics part of pharmacology and managing 
the demands of patients in particular parents of young children 
integrated in communication skills sessions. However, targeted 
“antibiotic” sessions in the format of problem-based learning are 
absolutely necessary to integrate all aspects of the topic.23 Apart 
from formal lectures, interactive learning with case vignettes, 
PowerPoint presentations and role play can be particularly appro-
priate for this topic. Elective rather than core modules are par-
ticularly suitable for discussions in small groups. Potential topics 
are case studies, e.g., with questions and answer sessions, illus-
trating the evidence base of surgical prophylaxis. As an example, 
the University of Rotterdam (The Netherlands) has included 
a one-week module on several concepts of antimicrobial resis-
tance, hygiene and prudent antibiotic prescribing in the core cur-
riculum of the second year of medical school. The University of 
Nijmegen offers an additional elective, problem-based module 
organ specialist (e.g., urologist) may not have the full required 
background for implementing the general principles of prudent 
antibiotic prescribing in the microbiological diagnostic and 
therapeutic management of urological patients. With worldwide 
increasing resistance data, multidisciplinary guideline develop-
ment of national and local guidelines becomes of the utmost 
importance. The ADAPTE framework (www.adapte.org) can 
be used to minimize barriers to the development and acceptance 
of guidelines.17 In particular, guidelines must be evidence-based 
and developed by a multidisciplinary group, involving all key 
stakeholders to foster acceptance and ownership. National or 
international guidelines should be adapted to the local context 
to ensure relevance for local practice and policies. Transparent 
reporting is essential to promote confidence in the recommenda-
tions of the adapted guideline and flexible, easily accessible for-
mats must be used (booklet, poster, smartphone applications...). 
In Canada, the CanMEDS Physician Competency framework 
describes the knowledge, skills and abilities that specialist physi-
cians need for better patient outcomes.37 This model has been 
adapted around the world in the health profession and other 
professions.
In the hospitals, a multidisciplinary core group, including 
infectious diseases specialists, microbiologists, (clinical) pharma-
cists and/or an antibiotic stewardship team must be involved in 
the development and implementation of a local educational pro-
gram on prudent antibiotic prescribing. In the Netherlands, gen-
eral practitioners (GPs) organize regional therapy focus groups 
where they discuss prescribing practices with pharmacists.
The teachers delivering the educational sessions must also 
be trained, both regarding the available educational strategies 
and the current literature on antimicrobial stewardship. As an 
example, the project “ABS International” implemented a train-
ing program for national antibiotic stewardship trainers in nine 
European countries, and offered them standard tools for imple-
menting an antibiotic stewardship program in their hospitals 
(e.g., guidelines for treatment and surgical prophylaxis, orga-
nizational measures, tools to analyze consumption data...).38 
Table 2. main learning outcomes used to design antibiotic stewardship workshops
Measuring antibiotic 
use
• Identify sources of data and understand how to measure antimicrobial use in the community and in hospitals
• Select proper measurement units to describe the volume of antimicrobial use
• Interpret antimicrobial use data locally and within a multicenter network (benchmarking)
• Choose and apply a method to study the relationship between antimicrobial prescribing and bacterial resistance
Auditing antibiotic use • Choose and apply an audit methodology for monitoring the quality of antimicrobial prescriptions
Improving antibiotic 
use
• Identify the steps and sources for evidence-based guideline development
• Describe the elements needed to launch a stewardship program in hospitals Identify barriers encountered in 
antimicrobial Stewardship programs and how to overcome them
• Make sense of interpersonal aspects of implementing change
• Identify possible intervention strategies (and their relative advantages and disadvantages) which could be implement-
ed in a hospital
• Identify the electronic antimicrobial drug prescribing aids and their advantages and disadvantages
• Build national and international support for Antimicrobial Stewardship programs
• Select a proper method to study the effect of interventions in hospitals
• Describe how an individual hospital can determine if its antimicrobial management program was economically suc-
cessful and if it had an impact on bacterial resistance
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junior doctors and other new clinical staff has been produced and 
made available for antimicrobial management teams and other 
staff involved in training. This endeavor has been developed and 
taught by NES (www.nes.scot.nhs.uk/education-and-training/
by-theme-initiative/healthcare-associated-infections/training-
resources/antimicrobials-in-clinical-practice.aspx).
Specialist training. The format of internship/specialist train-
ing of medical doctors is very variable both regarding the onset of 
exposure to patients, the duration, type of training and responsi-
bilities within Europe and the world which renders standardiza-
tion of learning outcomes very difficult. This period is extremely 
crucial for shaping behavior, as juniors start to copy the behavior 
of their supervisors within the first weeks in the hospital.27 The 
same principles used for undergraduates apply, and competen-
cies and learning outcomes must be clearly defined. The impact 
of learning sessions can be enhanced by measurement of current 
practice, and the use of quality improvement strategies.25,40,41
Strong political support is necessary for a curriculum pro-
gram to be successfully implemented. As an example, in the 
UK, the General Medical Council requested in 2009 that all 
postgraduate deans and Royal Colleges ensure infection preven-
tion and control and antimicrobial prescribing become standard 
practice implemented in all clinical settings, and that they are 
strongly emphasized in undergraduate and postgraduate medi-
cal training.40
Postgraduate level. Up to now, most initiatives on educa-
tion in antimicrobial stewardship have been deployed in the 
postgraduate setting. A considerable effort has been put into 
education in hospitals. Many interventional programs to opti-
mize antibiotic use have been conducted worldwide, and to a 
lesser extent in primary care.42,43 Intervention strategies have 
been categorized as educational, restrictive and supportive 
(Table 3). A multifaceted approach is favored to improve anti-
biotic use.1 Education is an essential element of any hospital 
program designed to influence antibiotic prescribing behavior. 
Educational measures are usually more popular among clini-
cians than restrictive measures.29,44 However, passive educa-
tion alone (lectures, educational events, leaflets and handouts), 
without incorporation of active intervention, has been shown 
only marginally effective in changing antimicrobial prescribing 
practices and has not demonstrated a sustained impact.1,43 In 
many places the limited success of in-hospital education may 
be partly due to the rapid turnover of junior staff and the dif-
ficulty in maintaining a local continuous educational program. 
Printed educational materials and educational conferences alone 
also have had little effect on changing prescribing practices for 
antibiotics or other medications in the outpatient setting. Face-
to-face and one-on-one educational sessions provided by physi-
cians are based on established principles of behavioral science 
and market research and communications theory. This type 
of education has been used intensively and successfully by the 
pharmaceutical industry. The approach in antimicrobial stew-
ardship has proved to be a practical, effective and safe method 
for reducing excessive broad-spectrum antibiotic use, but it is 
costly and labor-intensive.45 Clinical pathways have successfully 
been used to implement prudent antibiotic strategies, such as 
on antibiotic policy for third year students, treating the history 
of infectious diseases, hygiene and infection control, antibiotic 
guidelines, principles of prophylaxis and laboratory techniques 
among others.
In Scotland, for example, an extensive range of e-learning 
resources have been developed to train both undergraduate 
and postgraduate healthcare professionals on prudent antibi-
otic prescribing.39 Such training is mandatory for junior doc-
tors. Also in the UK, the Prudent Antibiotic User (PAUSE, 
www.pause-online.org.uk) is a website of shared standardized 
teaching materials for prudent antimicrobial prescribing for use 
in the undergraduate medical curriculum. PAUSE provides stan-
dardized teaching aides for all educators of antibiotic prescrib-
ing based on patient-focused, reflective learning. Resources are 
designed to enable students to prepare for interactive sessions to 
compare standard patient vignettes with their own clinical expe-
rience. The structured preparation required of the students is a 
key to success. The interactive discussion sessions focus on learn-
ing prudent antibiotic prescribing through reflective practice. 
Prepared materials in relation to structure and content for each 
interactive session are available for tutors to use (in a PowerPoint 
format). These resources include patient histories, clinical signs, 
investigations and questions on diagnosis, assessing severity, 
appropriate prescribing, public health issues and patient man-
agement. Best practice statements and core resource lists are also 
available. In addition guideline answers to the questions with 
feedback are provided, including inappropriate responses and the 
corresponding reasons. The materials may be shared, reproduced 
and modified as necessary. Another example is the educational 
work conducted by the Scottish Antimicrobial Prescribing Group 
(SAPG), hosted by the Scottish Medicines Consortium (SMC) 
in Scotland. The educational program is led by NHS Education 
for Scotland (NES) and involves scoping and development of 
training materials on antimicrobial stewardship both for under-
graduate and postgraduate healthcare professionals. A range 
of online resources are available on the website (www.nes.scot.
nhs.uk/education-and-training/by-theme-initiative/healthcare-
associated-infections/online-short-courses.aspx). A framework 
of learning outcomes for antimicrobial stewardship that aligns 
with The Scottish Doctor report has been developed after broad 
consultation, and SAPG has recommended its adoption into the 
curricula of the five Scottish medical schools. The framework is 
also being evaluated by the two Schools of Pharmacy in Scotland 
to ensure that those learning outcomes applicable to pharmacists 
are covered by their undergraduate curricula. Such training is 
mandatory for junior doctors.39
Internship, foundation year training (UK). Recently, the 
training programs of graduated doctors into primary care or spe-
cialty have been the subjects of reforms in many countries. In 
Scotland, the Doctors Online Training System (DOTS), a man-
datory web-based education resource for all foundation train-
ing doctors, was revised to highlight current issues in prudent 
antibiotic prescribing in 2009.39 Access to the DOTS program 
has been extended to allow other medical staff, pharmacists and 
non-medical prescribers to participate in the training, and a pri-
mary care module has also been added. An induction pack for 
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the European Antibiotic Awareness Day website (http://ecdc.
europa.eu/en/EAAD/Pages/Home.aspx/).
In the US, the CDC started its campaign “Get Smart for 
Healthcare” in the same year. It focuses on improving antibiotic 
use in inpatient healthcare facilities starting with hospitals and 
then expanding to long-term care facilities. The goal of the cam-
paign is to optimize the use of antimicrobial agents in inpatient 
healthcare settings by focusing on strategies to help hospitals and 
other inpatient facilities implement interventions to improve anti-
biotic use. The CDC provides slides, fact sheets, and an annotated 
bibliography on the evidence base of outcomes among other tools 
on its website (www.cdc.gov/getsmart/healthcare/). The CDC 
also collaborates with the Society for Healthcare Epidemiology 
of America (SHEA) to develop simple implementation tools, and 
with the Institute for Healthcare Improvement (IHI) and SHEA 
to develop a driver diagram with practical antibiotic stewardship 
implementation strategies.
In view of training the trainers, multiple educational post-
graduate courses and workshops have been organized in the past 
decade, targeting a multidisciplinary group of clinicians includ-
ing infectious diseases specialists, clinical microbiologists, (ID) 
hospital pharmacists and hospital epidemiologists.
The ESCMID study group for Antibiotic Policies (ESGAP, 
available at www.escmid.org/esgap) has been conducting 
postgraduate international education courses “Antimicrobial 
Stewardship: Measuring, auditing and improving,” held bi-
annually before the European Conference on Microbiology and 
Infectious Diseases (ECCMID). Up to now, seven courses have 
been organized, training over 400 medical doctors, scientists, 
and clinical pharmacists over the past decade. Another one-day 
course is conducted as a pre-ICAAC workshop (www.icaac.org/
workshops). ESGAP has also published its efforts in making an 
inventory of antimicrobial stewardship websites.48
the de-escalation pathway described by Singh et al. to curb inap-
propriate antibiotic use for pulmonary infiltrates in the intensive 
care unit in their hospital.46 Clinical pathways, audit and feed-
back and the development of practice guidelines are discussed 
more extensively in another part of this issue. In conclusion, 
according to the Cochrane review, a wide variety of interven-
tions have been proven successful in changing antibiotic pre-
scribing to hospital inpatients.43 Any interventions can work 
some of the time.41 Hospitals are complex institutions and what 
is effective in one setting may not be effective in another.
An open access curriculum has been developed in the con-
text of the European Union funded research project “Genomics 
to combat resistance against antibiotics in community-acquired 
lower respiratory tract infections in Europe” (GRACE). It con-
tains a series of postgraduate courses and workshops and per-
mitted the creation of an open access e-Learning portal. A total 
of 153 presentations matching the topics within the curriculum, 
slide material, handouts and 104 webcasts are available through 
this portal. The website is a considerable source of knowledge, 
mainly on diagnostics and much less on therapy (www.grace-
edut.org/pages/default.aspx?id=1617).47
Also on a European level, the European Centre for Disease 
Prevention and Control (ECDC) chose the hospital prescrib-
ers as target for their European Antibiotic Awareness Day cam-
paign in 2010. The aim of the toolkit was to support efforts at 
a national level to increase prudent use of antibiotics in hospi-
tals through dissemination of evidence-based educational and 
information materials. The toolkit contains template materials 
and evidence-based key messages which may be adapted for use 
at national level, and suggests tactics for getting the messages 
regarding prudent use of antibiotics through to the target audi-
ences. The template toolkit materials and more information 
about the European Antibiotic Awareness Day are available on 
Table 3. main antimicrobial stewardship strategies recommended in the international literature to improve antibiotic use at the hospital level1,49
Educational measures and active interventions
passive educational measures • Developing/updating local antibiotic guidelines
• Educational sessions, workshops, local conferences
active interventions • Clinical rounds discussing cases
• Prospective audit with intervention and feedback
• Reassessment of antibiotic prescriptions, with streamlining and de-escalation of therapy
• Academic detailing, educational outreach visits
Restrictive measures • Limiting number of antibiotics on the hospital formulary
• Antibiotic order form (compulsory)
• Automatic stop order
• Formulary restriction and preauthorization
• Limiting reporting of susceptibilities by the microbiology laboratory
• Regulating contacts with the pharmaceutical industry
Supportive/supplemental measures • Multidisciplinary antimicrobial stewardship team
• Consultancy service (infectious diseases, pharmacy, microbiology)
• Computer-assisted management program
• Parenteral to oral conversion
• Therapeutic drug monitoring service
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Recommendations
• Education on prudent antimicrobial prescribing should start 
early in the undergraduate curriculum, preferably in the third 
year of undergraduate training in medicine and correspondent 
level in non-medical curricula of pharmacy, dentistry, mid-
wifery, nursing and veterinary medicine to reach all health 
professionals.
• This requires commitment from medical schools on a 
national level to agree that antimicrobial stewardship is among 
the necessary skills to practice.
• The teaching of principles preparing for antimicrobial stew-
ardship should be guaranteed by the development of learning 
outcomes and competencies and the appropriate evaluation.
• Postgraduate education should then focus on implementa-
tion and measurement of practice, with additional supportive 
and restrictive measures.
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Conclusion
After 30 years of antibiotic policy activities trying to curb anti-
biotic resistance, some reflection is appropriate. Antimicrobial 
stewardship interventions have mainly been conducted at the 
postgraduate level, aiming at changing the behavior of profes-
sionals. This has proven extremely difficult and frustrating. Quite 
paradoxically, although a thorough analysis is of the situation is 
lacking, only minimal investment has been put in the antimi-
crobial stewardship education in the undergraduate curriculum 
in most countries. This is, in our opinion, a missed opportunity 
for the future. It seems obvious that antimicrobial stewardship 
is likely to be more successful when started much earlier, at the 
time when knowledge, attitude and behavior of professionals are 
being shaped.
Therefore, it is now crucial to focus on an adapted undergrad-
uate medical/professional curriculum that teaches all necessary 
principles of microbiology, infectious diseases and clinical phar-
macology, with emphasis on the principles of prudent prescribing 
in an adequate format. Appropriate curricula on antimicrobial 
stewardship are a joint responsibility of the academia and the 
ministries of Health and Education.
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